Area of research
Cardiology and Cardiovascular Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Cardiovascular Disease and Adiposity, Cardiovascular Health and Disease Prevention, Blood Pressure and Hypertension Studies, and Cardiovascular Function and Risk Factors.
Circulating miR-10b-5p as a candidate biomarker of atrial fibrillation recurrence after catheter ablation: a two-phase translational study.
Proprotein Convertase Subtilisin/Kexin Type 9 and Atherosclerotic Plaque Progression: A Systematic Review and Meta-Analysis of Intravascular Imaging Studies.
Sex and gender differences in coronary pathophysiology and ischaemic heart disease.
The European Society of Cardiology Working Group on Coronary Pathophysiology and Microcirculation.
Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers
Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers.
Lipoprotein(a) and calcific aortic valve disease initiation and progression: a systematic review and meta-analysis.
Reply to: assessment of pericoronary adipose tissue attenuation.
The ESC Working Group on Coronary Pathophysiology and Microcirculation.
Risk factors profile of young and older patients with myocardial infarction.
Cardiovascular risk stratification by coronary computed tomography angiography imaging: current state-of-the-art.
Mechanisms, therapeutic implications, and methodological challenges of gut microbiota and cardiovascular diseases: a position paper by the ESC Working Group on Coronary Pathophysiology and Microcirculation.
Functional and structural adaptations of the coronary macro- and microvasculature to regular aerobic exercise by activation of physiological, cellular, and molecular mechanisms: ESC Working Group on Coronary Pathophysiology and Microcirculation position paper.
The Role of Endothelial Related Circulating Biomarkers in
COVID-19. A Systematic Review and Meta-analysis
Association of Growth Differentiation Factor 15 with Arterial Stiffness and
Endothelial Function in Subpopulations of Patients with Coronary Artery
Disease: A Proof-of-Concept Study
Vaccination Against SARS-CoV-2 Protects from COVID-19-induced Endothelial
Dysfunction
Screening of asymptomatic patients with elevated lipoprotein(a) levels by coronary computed tomography angiography.
Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA).
MicroRNAs as Biomarkers in Hypertrophic Cardiomyopathy: Current State of the Art
Hypertensive urgencies during the first wave of COVID-19 pandemic in a tertiary hospital setting: A “U” shaped alarming curve.
Evaluating the Safety and Tolerability of Azilsartan Medoxomil Alone or in Combination With Chlorthalidone in the Management of Hypertension: A Systematic Review.
MicroRNAs in the Management of Heart Failure
The Hellenic Journal of Cardiology: a 64-year voyage of discovery from the cradle of European civilization to the world.
Insulin-induced vascular redox dysregulation in human atherosclerosis is ameliorated by dipeptidyl peptidase 4 inhibition.
Antithrombotic Treatment in Diabetes Mellitus: A Review of the Literature about Antiplatelet and Anticoagulation Strategies Used for Diabetic Patients in Primary and Secondary Prevention
Cardiovascular Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
Novel Antidiabetic Agents: Cardiovascular and Safety Outcomes
The Role of microRNAs in the Development of Type 2 Diabetes Complications
Antiplatelet and Antithrombotic Therapy After Patent Foramen Oval and Atrial Septal Defect Closure
Novel Perspective for Antithrombotic Therapy in TAVI